InnoCan Pharma Corporation (INNPF)

InnoCan Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	28.83	29.44	13.66	2.56	0.2	0.01
Revenue Growth (YoY)	18.20%	115.55%	433.69%	1205.61%	2350.00%	-
Cost of Revenue	3.33	3.25	1.68	0.45	0.08	0.01
Gross Profit	25.5	26.19	11.98	2.11	0.12	0
Selling, General & Admin	24.12	25.89	13.99	6.85	6.2	2.98
Research & Development	1.06	1.55	1.8	1.53	1.4	1.74
Operating Expenses	25.18	27.43	15.78	8.37	7.6	4.73
Operating Income	0.32	-1.25	-3.8	-6.27	-7.48	-4.73
Interest Expense	-0.01	-0.01	-	-0	-0.01	-0.01
Currency Exchange Gain (Loss)	0.09	-0.04	0	-0.42	-0.29	0.03
Other Non Operating Income (Expenses)	0.99	2.22	-0.24	2.8	-2.31	-5.25
Pretax Income	0.63	0.92	-4.03	-3.89	-10.09	-9.95
Income Tax Expense	0.94	1.18	0.21	0	-	-
Earnings From Continuing Operations	-0.31	-0.26	-4.25	-3.89	-10.09	-9.95
Minority Interest in Earnings	-1.27	-1.57	-0.45	0.13	0.04	-
Net Income	-1.58	-1.83	-4.7	-3.76	-10.05	-9.95
Net Income to Common	-1.58	-1.83	-4.7	-3.76	-10.05	-9.95
Shares Outstanding (Basic)	288	280	257	249	225	162
Shares Outstanding (Diluted)	288	280	257	249	225	162
Shares Change (YoY)	7.00%	8.96%	3.23%	10.87%	38.59%	34.30%
EPS (Basic)	-0.01	-0.01	-0.02	-0.02	-0.04	-0.06
EPS (Diluted)	-0.01	-0.01	-0.02	-0.02	-0.04	-0.06
Free Cash Flow	-0.47	-1.59	-3.95	-6.09	-6.67	-3.69
Free Cash Flow Per Share	-0.00	-0.01	-0.01	-0.02	-0.03	-0.02
Gross Margin	88.45%	88.96%	87.71%	82.34%	61.73%	37.50%
Operating Margin	1.10%	-4.24%	-27.85%	-244.86%	-3816.33%	-59062.50%
Profit Margin	-5.47%	-6.23%	-34.41%	-147.09%	-5126.02%	-124412.50%
Free Cash Flow Margin	-1.63%	-5.42%	-28.92%	-238.10%	-3403.06%	-46087.50%
EBITDA	0.35	-1.21	-3.77	-6.23	-7.44	-4.69
EBITDA Margin	1.22%	-4.12%	-27.61%	-243.49%	-	-
D&A For EBITDA	0.03	0.04	0.03	0.04	0.04	0.04
EBIT	0.32	-1.25	-3.8	-6.27	-7.48	-4.73
EBIT Margin	1.10%	-4.24%	-27.85%	-244.86%	-	-
Effective Tax Rate	148.97%	128.51%	-	-	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.